BMO Capital analyst Matthew Borsch maintained a Buy rating on Aveanna Healthcare Holdings (AVAH) today and set a price target of $17.00. The company’s shares closed last Thursday at $11.65.
According to TipRanks.com, Borsch is a 3-star analyst with an average return of 7.2% and a 58.8% success rate. Borsch covers the Healthcare sector, focusing on stocks such as Molina Healthcare, HCA Healthcare, and Addus Homecare.
Currently, the analyst consensus on Aveanna Healthcare Holdings is a Strong Buy with an average price target of $15.55, implying a 33.5% upside from current levels. In a report issued on May 24, Credit Suisse also initiated coverage with a Buy rating on the stock with a $16.00 price target.
See today’s analyst top recommended stocks >>
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Aveanna Healthcare Holdings Inc is a diversified home care platform focused on providing care to medically complex, high-cost patient populations. It directly address the most pressing challenges facing the U.S. healthcare system by providing safe, high-quality care in the home, the lower cost care setting preferred by patients.
